相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
S. L. Stocker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation
A. R. Shuldiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Russell A. Miller et al.
NATURE (2013)
The potential impact of pharmacogenetic testing on medication adherence
S. B. Haga et al.
PHARMACOGENOMICS JOURNAL (2013)
Childhood obesity and type 2 diabetes: the frightening epidemic
Nicola Santoro
WORLD JOURNAL OF PEDIATRICS (2013)
Disposition of metformin: Variability due to polymorphisms of organic cation transporters
Oliver Zolk
ANNALS OF MEDICINE (2012)
Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey
E. J. Stanek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
The C Allele of ATM rs11212617 Does Not Associate With Metformin Response in the Diabetes Prevention Program
Jose C. Florez et al.
DIABETES CARE (2012)
Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
George A. Bray et al.
DIABETES CARE (2012)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
A gene variant near ATM is significantly associated with metformin treatment response in type 2 diabetes: a replication and meta-analysis of five cohorts
N. van Leeuwen et al.
DIABETOLOGIA (2012)
The role of ATM in response to metformin treatment and activation of AMPK
Angela Woods et al.
NATURE GENETICS (2012)
The role of ATM in response to metformin treatment and activation of AMPK
Sook Wah Yee et al.
NATURE GENETICS (2012)
A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes
Phil Zeitler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Metformin pathways: pharmacokinetics and pharmacodynamics
Li Gong et al.
PHARMACOGENETICS AND GENOMICS (2012)
KCNQ1 variants and response to repaglinide treatment in patients with Type 2 diabetes
Ivan Tkac
PHARMACOGENOMICS (2012)
Serine racemase rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with diabetes mellitus type 2
Min Dong et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to Metformin
J. H. Choi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
M. V. Relling et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
Kaixin Zhou et al.
NATURE GENETICS (2011)
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
Mette M. H. Christensen et al.
PHARMACOGENETICS AND GENOMICS (2011)
The Cardiovascular Effects of Metformin: Further Reasons to Consider An Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus
Giovanni Anfossi et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program
Kathleen A. Jablonski et al.
DIABETES (2010)
Organic Cation Transporter 1 Polymorphisms Predict the Metabolic Response to Metformin in Women with the Polycystic Ovary Syndrome
Alessandra Gambineri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin
Ligong Chen et al.
PHARMACOGENETICS AND GENOMICS (2010)
Pharmacy Benefit Managers, Pharmacies, and Pharmacogenomic Testing: Prescription for Progress?
Eric J. Topol
SCIENCE TRANSLATIONAL MEDICINE (2010)
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL
Helena W. Rodbard et al.
ENDOCRINE PRACTICE (2009)
Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
M. L. Becker et al.
PHARMACOGENOMICS JOURNAL (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Impact of Metformin, Oral Contraceptives, and Lifestyle Modification on Polycystic Ovary Syndrome in Obese Adolescent Women: Do We Need a New Drug?
Richard S. Legro
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions
Robert E. Ratner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics
Y. Shu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care
M. N. Cook et al.
DIABETIC MEDICINE (2007)
Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
Eriko Shikata et al.
JOURNAL OF HUMAN GENETICS (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
